

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.41343911 |
| 2 | B cell receptor signaling pathway (GO:0050853) | 6.24153927 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.97506243 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.92915581 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.41568789 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.41568789 |
| 7 | regulation of B cell differentiation (GO:0045577) | 4.70924632 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.50640237 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.50640237 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.50640237 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.50640237 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.50640237 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.50640237 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.49957386 |
| 15 | negative regulation of cell killing (GO:0031342) | 4.48075279 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.48075279 |
| 17 | positive regulation of B cell differentiation (GO:0045579) | 4.40987020 |
| 18 | positive thymic T cell selection (GO:0045059) | 4.34882141 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.17050416 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 4.12406172 |
| 21 | leukocyte aggregation (GO:0070486) | 3.97699455 |
| 22 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.82332536 |
| 23 | respiratory burst (GO:0045730) | 3.80223154 |
| 24 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.76883535 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 3.75043610 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.68651075 |
| 27 | B cell proliferation (GO:0042100) | 3.66511732 |
| 28 | mature B cell differentiation (GO:0002335) | 3.63750209 |
| 29 | response to interleukin-15 (GO:0070672) | 3.59663162 |
| 30 | NIK/NF-kappaB signaling (GO:0038061) | 3.57534233 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 3.54026483 |
| 32 | positive regulation of antigen processing and presentation (GO:0002579) | 3.48627706 |
| 33 | positive regulation of interferon-alpha production (GO:0032727) | 3.41095158 |
| 34 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.39511851 |
| 35 | negative regulation of B cell proliferation (GO:0030889) | 3.38558146 |
| 36 | cellular response to interleukin-15 (GO:0071350) | 3.38547398 |
| 37 | B cell homeostasis (GO:0001782) | 3.38021079 |
| 38 | cellular response to zinc ion (GO:0071294) | 3.37585819 |
| 39 | thymic T cell selection (GO:0045061) | 3.36523822 |
| 40 | negative thymic T cell selection (GO:0045060) | 3.36113097 |
| 41 | response to peptidoglycan (GO:0032494) | 3.35505961 |
| 42 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.30714557 |
| 43 | cellular extravasation (GO:0045123) | 3.30184921 |
| 44 | regulation of interferon-alpha production (GO:0032647) | 3.26547338 |
| 45 | defense response to protozoan (GO:0042832) | 3.26181614 |
| 46 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.25295513 |
| 47 | response to muramyl dipeptide (GO:0032495) | 3.22896729 |
| 48 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.22800275 |
| 49 | negative regulation of phagocytosis (GO:0050765) | 3.19243055 |
| 50 | neutrophil activation (GO:0042119) | 3.16646493 |
| 51 | neutrophil activation involved in immune response (GO:0002283) | 3.15640013 |
| 52 | T cell migration (GO:0072678) | 3.15116624 |
| 53 | negative T cell selection (GO:0043383) | 3.14997063 |
| 54 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.13756659 |
| 55 | regulation of B cell proliferation (GO:0030888) | 3.12002999 |
| 56 | lymphocyte homeostasis (GO:0002260) | 3.10717214 |
| 57 | positive T cell selection (GO:0043368) | 3.10693795 |
| 58 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.07250233 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.06047071 |
| 60 | germinal center formation (GO:0002467) | 3.05830534 |
| 61 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00888179 |
| 62 | response to protozoan (GO:0001562) | 3.00061003 |
| 63 | T cell selection (GO:0045058) | 2.98012125 |
| 64 | regulation of B cell apoptotic process (GO:0002902) | 2.97513256 |
| 65 | negative regulation of interleukin-12 production (GO:0032695) | 2.96761968 |
| 66 | I-kappaB phosphorylation (GO:0007252) | 2.96286315 |
| 67 | granulocyte activation (GO:0036230) | 2.95846443 |
| 68 | tolerance induction (GO:0002507) | 2.94644667 |
| 69 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.94061616 |
| 70 | positive regulation of histone deacetylation (GO:0031065) | 2.93833246 |
| 71 | T cell homeostasis (GO:0043029) | 2.93686276 |
| 72 | leukocyte cell-cell adhesion (GO:0007159) | 2.90917441 |
| 73 | B cell mediated immunity (GO:0019724) | 2.90599085 |
| 74 | response to host immune response (GO:0052572) | 2.88059280 |
| 75 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.88059280 |
| 76 | negative regulation of histone methylation (GO:0031061) | 2.85509868 |
| 77 | regulation of mast cell degranulation (GO:0043304) | 2.85357593 |
| 78 | regulation of antigen processing and presentation (GO:0002577) | 2.84957087 |
| 79 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.83211698 |
| 80 | neutrophil mediated immunity (GO:0002446) | 2.82998988 |
| 81 | mononuclear cell proliferation (GO:0032943) | 2.80829690 |
| 82 | natural killer cell mediated immunity (GO:0002228) | 2.79611180 |
| 83 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.79611180 |
| 84 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.79583010 |
| 85 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.77616011 |
| 86 | positive regulation of mast cell degranulation (GO:0043306) | 2.77616011 |
| 87 | lymphocyte proliferation (GO:0046651) | 2.75858679 |
| 88 | positive regulation of mast cell activation (GO:0033005) | 2.75628421 |
| 89 | positive regulation of Rap GTPase activity (GO:0032854) | 2.73781064 |
| 90 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.72593680 |
| 91 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.72593680 |
| 92 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.72593680 |
| 93 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.72011033 |
| 94 | myeloid cell activation involved in immune response (GO:0002275) | 2.71734481 |
| 95 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.70815244 |
| 96 | positive regulation of B cell activation (GO:0050871) | 2.68062146 |
| 97 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.67729025 |
| 98 | response to host (GO:0075136) | 2.67729025 |
| 99 | response to host defenses (GO:0052200) | 2.67729025 |
| 100 | positive regulation of B cell proliferation (GO:0030890) | 2.64454989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.22445585 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.58977110 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 4.12654194 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.98578890 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.76884901 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.59109448 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.48124076 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.42211441 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.41009092 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.26147723 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.22271754 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.09518638 |
| 13 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.04941074 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83806189 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.74115613 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64755248 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59146839 |
| 18 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.54289688 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.51055109 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.41296806 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.34220892 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 2.32206620 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.30370806 |
| 24 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.29191444 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.28231070 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.26731502 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.26283182 |
| 28 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.24158954 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.16078447 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.13874800 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.12546871 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10391975 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08278860 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06552975 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.05850668 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.02881022 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.95754914 |
| 38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.94114496 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.92902319 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.92006323 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91513868 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.83099411 |
| 43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.74907169 |
| 44 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.74590479 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.74524880 |
| 46 | MAF_26560356_Chip-Seq_TH2_Human | 1.68830433 |
| 47 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59988091 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.50533419 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43872611 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42325742 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41692151 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41138578 |
| 53 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.41012558 |
| 54 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38744385 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38159090 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.34810554 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31282495 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31191764 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28706011 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27779738 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27578198 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22962725 |
| 63 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.21192580 |
| 64 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.18252266 |
| 65 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13851131 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.10421771 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10353092 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10053986 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08856655 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06384873 |
| 71 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.06335145 |
| 72 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05894609 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03902033 |
| 74 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03106788 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00028783 |
| 76 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99965884 |
| 77 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99514279 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97812150 |
| 79 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.97017201 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97012012 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96666417 |
| 82 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.94100954 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93265611 |
| 84 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.89759828 |
| 85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87170951 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87054554 |
| 87 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.86989364 |
| 88 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.85133320 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80701828 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80568209 |
| 91 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.79992015 |
| 92 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79959409 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.78375578 |
| 94 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.78073310 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77930396 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.77606464 |
| 97 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.77286573 |
| 98 | P300_27268052_Chip-Seq_Bcells_Human | 0.75942539 |
| 99 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.75936846 |
| 100 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.75532121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.79827547 |
| 2 | MP0003303_peritoneal_inflammation | 4.38446032 |
| 3 | MP0001800_abnormal_humoral_immune | 3.98713087 |
| 4 | MP0001790_abnormal_immune_system | 3.93100389 |
| 5 | MP0005387_immune_system_phenotype | 3.93100389 |
| 6 | MP0000685_abnormal_immune_system | 3.33780236 |
| 7 | MP0002452_abnormal_antigen_presenting | 3.26542128 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.10777316 |
| 9 | MP0002723_abnormal_immune_serum | 2.85344569 |
| 10 | MP0005671_abnormal_response_to | 2.82879122 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.80969155 |
| 12 | MP0001819_abnormal_immune_cell | 2.74473175 |
| 13 | MP0003436_decreased_susceptibility_to | 2.59536639 |
| 14 | MP0002398_abnormal_bone_marrow | 2.57793822 |
| 15 | MP0002419_abnormal_innate_immunity | 2.50021996 |
| 16 | MP0004510_myositis | 2.44600675 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.42804073 |
| 18 | MP0005025_abnormal_response_to | 2.37112789 |
| 19 | MP0000716_abnormal_immune_system | 2.34782089 |
| 20 | MP0000689_abnormal_spleen_morphology | 2.23769070 |
| 21 | MP0009785_altered_susceptibility_to | 2.21560537 |
| 22 | MP0001873_stomach_inflammation | 2.09336910 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.07035170 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.04922024 |
| 25 | MP0002722_abnormal_immune_system | 2.00453013 |
| 26 | MP0002405_respiratory_system_inflammati | 1.98963190 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.98753577 |
| 28 | MP0000569_abnormal_digit_pigmentation | 1.98744730 |
| 29 | MP0009278_abnormal_bone_marrow | 1.96782695 |
| 30 | MP0002429_abnormal_blood_cell | 1.95361319 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.87355672 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 1.78152658 |
| 33 | MP0004947_skin_inflammation | 1.76387049 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.75063857 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.73134365 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.72843029 |
| 37 | MP0010307_abnormal_tumor_latency | 1.62997731 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.61037797 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.59745375 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.57889618 |
| 41 | MP0005310_abnormal_salivary_gland | 1.57169984 |
| 42 | MP0001853_heart_inflammation | 1.56097021 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.54622903 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.53962586 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.48189167 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.45175020 |
| 47 | MP0006082_CNS_inflammation | 1.44571375 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.40042796 |
| 49 | MP0010352_gastrointestinal_tract_polyps | 1.32038448 |
| 50 | MP0008057_abnormal_DNA_replication | 1.31809043 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.29452988 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.29452988 |
| 53 | MP0003448_altered_tumor_morphology | 1.22910641 |
| 54 | MP0008469_abnormal_protein_level | 1.14561969 |
| 55 | MP0002006_tumorigenesis | 1.14191573 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.07795928 |
| 57 | MP0009840_abnormal_foam_cell | 1.07689046 |
| 58 | MP0003566_abnormal_cell_adhesion | 1.07232091 |
| 59 | MP0003866_abnormal_defecation | 1.06692976 |
| 60 | MP0003077_abnormal_cell_cycle | 1.04653544 |
| 61 | MP0002933_joint_inflammation | 1.04317371 |
| 62 | MP0003693_abnormal_embryo_hatching | 1.01552505 |
| 63 | MP0002019_abnormal_tumor_incidence | 0.97531512 |
| 64 | MP0000015_abnormal_ear_pigmentation | 0.97208017 |
| 65 | MP0010234_abnormal_vibrissa_follicle | 0.95968070 |
| 66 | MP0003111_abnormal_nucleus_morphology | 0.95009580 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 0.94638496 |
| 68 | MP0003091_abnormal_cell_migration | 0.88964357 |
| 69 | MP0000858_altered_metastatic_potential | 0.87850207 |
| 70 | MP0008961_abnormal_basal_metabolism | 0.87230388 |
| 71 | MP0000604_amyloidosis | 0.86990835 |
| 72 | MP0010094_abnormal_chromosome_stability | 0.82855627 |
| 73 | MP0000490_abnormal_crypts_of | 0.82759581 |
| 74 | MP0001851_eye_inflammation | 0.79216140 |
| 75 | MP0009764_decreased_sensitivity_to | 0.76083432 |
| 76 | MP0002136_abnormal_kidney_physiology | 0.73055079 |
| 77 | MP0005621_abnormal_cell_physiology | 0.72406257 |
| 78 | MP0008260_abnormal_autophagy | 0.71803983 |
| 79 | MP0005166_decreased_susceptibility_to | 0.69971396 |
| 80 | MP0000350_abnormal_cell_proliferation | 0.69031587 |
| 81 | MP0003045_fibrosis | 0.67296760 |
| 82 | MP0001663_abnormal_digestive_system | 0.67218203 |
| 83 | MP0003453_abnormal_keratinocyte_physiol | 0.66857182 |
| 84 | MP0000371_diluted_coat_color | 0.65665386 |
| 85 | MP0008874_decreased_physiological_sensi | 0.64653792 |
| 86 | MP0005023_abnormal_wound_healing | 0.63687666 |
| 87 | MP0000313_abnormal_cell_death | 0.62624364 |
| 88 | MP0002928_abnormal_bile_duct | 0.61602181 |
| 89 | MP0000343_altered_response_to | 0.58088781 |
| 90 | MP0002877_abnormal_melanocyte_morpholog | 0.57285346 |
| 91 | MP0000249_abnormal_blood_vessel | 0.56569528 |
| 92 | MP0002998_abnormal_bone_remodeling | 0.56405696 |
| 93 | MP0009763_increased_sensitivity_to | 0.56024659 |
| 94 | MP0001986_abnormal_taste_sensitivity | 0.50524849 |
| 95 | MP0005384_cellular_phenotype | 0.50386749 |
| 96 | MP0002095_abnormal_skin_pigmentation | 0.49671356 |
| 97 | MP0000733_abnormal_muscle_development | 0.46013387 |
| 98 | MP0001730_embryonic_growth_arrest | 0.45772751 |
| 99 | MP0003828_pulmonary_edema | 0.45648712 |
| 100 | MP0004957_abnormal_blastocyst_morpholog | 0.45346902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 5.83577595 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.34243758 |
| 3 | Gastrointestinal stroma tumor (HP:0100723) | 5.18314602 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.08045343 |
| 5 | Cellulitis (HP:0100658) | 5.03722388 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.93037883 |
| 7 | Colitis (HP:0002583) | 4.75446556 |
| 8 | Inflammation of the large intestine (HP:0002037) | 4.42116124 |
| 9 | Recurrent bronchitis (HP:0002837) | 4.37939836 |
| 10 | Recurrent viral infections (HP:0004429) | 4.37816190 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.33611646 |
| 12 | IgM deficiency (HP:0002850) | 4.28276252 |
| 13 | Gastrointestinal inflammation (HP:0004386) | 4.27939510 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.17309242 |
| 15 | Meningitis (HP:0001287) | 4.07934703 |
| 16 | Chronic otitis media (HP:0000389) | 3.90755837 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.85061877 |
| 18 | Recurrent sinusitis (HP:0011108) | 3.80221562 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.79313806 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.79313806 |
| 21 | Vasculitis (HP:0002633) | 3.72145334 |
| 22 | Papilloma (HP:0012740) | 3.70698310 |
| 23 | Verrucae (HP:0200043) | 3.70698310 |
| 24 | Emphysema (HP:0002097) | 3.69973135 |
| 25 | Recurrent skin infections (HP:0001581) | 3.68541581 |
| 26 | Lymphopenia (HP:0001888) | 3.65849709 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.63539816 |
| 28 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.56627060 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 3.50915940 |
| 30 | Obstructive lung disease (HP:0006536) | 3.45742284 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.45742284 |
| 32 | Osteomyelitis (HP:0002754) | 3.33473158 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 3.29599169 |
| 34 | Restrictive lung disease (HP:0002091) | 3.15689127 |
| 35 | Abnormality of the fingertips (HP:0001211) | 3.15342168 |
| 36 | Abnormality of macrophages (HP:0004311) | 3.13760343 |
| 37 | Chronic sinusitis (HP:0011109) | 3.04101524 |
| 38 | IgA deficiency (HP:0002720) | 3.03101306 |
| 39 | Pustule (HP:0200039) | 2.95180109 |
| 40 | Recurrent pneumonia (HP:0006532) | 2.90260478 |
| 41 | Recurrent lower respiratory tract infections (HP:0002783) | 2.85210065 |
| 42 | Nasal polyposis (HP:0100582) | 2.84000792 |
| 43 | Myositis (HP:0100614) | 2.75594249 |
| 44 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.69712678 |
| 45 | Interstitial pulmonary disease (HP:0006530) | 2.65987325 |
| 46 | Gingivitis (HP:0000230) | 2.63877997 |
| 47 | Sepsis (HP:0100806) | 2.58534456 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.52913650 |
| 49 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.52694440 |
| 50 | Abnormality of T cells (HP:0002843) | 2.50543539 |
| 51 | Stomatitis (HP:0010280) | 2.49115617 |
| 52 | Thrombocytosis (HP:0001894) | 2.43539717 |
| 53 | Leukopenia (HP:0001882) | 2.43387390 |
| 54 | Increased IgE level (HP:0003212) | 2.40630844 |
| 55 | B lymphocytopenia (HP:0010976) | 2.39850898 |
| 56 | Abnormality of B cell number (HP:0010975) | 2.39850898 |
| 57 | Thyroiditis (HP:0100646) | 2.37053258 |
| 58 | Recurrent otitis media (HP:0000403) | 2.36752990 |
| 59 | Abnormality of the nasal mucosa (HP:0000433) | 2.35674843 |
| 60 | T lymphocytopenia (HP:0005403) | 2.34223779 |
| 61 | Bronchitis (HP:0012387) | 2.33884564 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.33664849 |
| 63 | Abnormality of T cell number (HP:0011839) | 2.31100347 |
| 64 | Papilledema (HP:0001085) | 2.26084240 |
| 65 | Hematochezia (HP:0002573) | 2.24990076 |
| 66 | Myocardial infarction (HP:0001658) | 2.24202329 |
| 67 | Lymphoma (HP:0002665) | 2.23337377 |
| 68 | Urticaria (HP:0001025) | 2.22832713 |
| 69 | Chest pain (HP:0100749) | 2.22627854 |
| 70 | Encephalitis (HP:0002383) | 2.19929532 |
| 71 | Skin ulcer (HP:0200042) | 2.19811218 |
| 72 | Pulmonary infiltrates (HP:0002113) | 2.17707117 |
| 73 | Periodontitis (HP:0000704) | 2.17437374 |
| 74 | Viral hepatitis (HP:0006562) | 2.16279144 |
| 75 | Small epiphyses (HP:0010585) | 2.13396461 |
| 76 | Prolonged bleeding time (HP:0003010) | 2.09399652 |
| 77 | Arterial thrombosis (HP:0004420) | 2.09280291 |
| 78 | Gingival bleeding (HP:0000225) | 2.08104609 |
| 79 | Leukocytosis (HP:0001974) | 2.02022551 |
| 80 | Chronic diarrhea (HP:0002028) | 2.01826929 |
| 81 | Arthralgia (HP:0002829) | 1.97614600 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 1.97246432 |
| 83 | Fatigue (HP:0012378) | 1.89489425 |
| 84 | Dysostosis multiplex (HP:0000943) | 1.87963314 |
| 85 | Increased density of long bones (HP:0006392) | 1.86970334 |
| 86 | Eosinophilia (HP:0001880) | 1.86755559 |
| 87 | Vacuolated lymphocytes (HP:0001922) | 1.86265360 |
| 88 | IgG deficiency (HP:0004315) | 1.85678253 |
| 89 | Mitral stenosis (HP:0001718) | 1.84913522 |
| 90 | Optic neuritis (HP:0100653) | 1.83253510 |
| 91 | Retrobulbar optic neuritis (HP:0100654) | 1.83253510 |
| 92 | Abnormal platelet function (HP:0011869) | 1.81994996 |
| 93 | Impaired platelet aggregation (HP:0003540) | 1.81994996 |
| 94 | Petechiae (HP:0000967) | 1.81447291 |
| 95 | Ulnar bowing (HP:0003031) | 1.77618461 |
| 96 | Orchitis (HP:0100796) | 1.77028565 |
| 97 | Abnormal platelet volume (HP:0011876) | 1.75771602 |
| 98 | Vertebral arch anomaly (HP:0008438) | 1.74831007 |
| 99 | Granulocytopenia (HP:0001913) | 1.72794588 |
| 100 | Epistaxis (HP:0000421) | 1.71153030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 6.38241129 |
| 2 | SIK2 | 2.74213706 |
| 3 | RIPK4 | 2.72160688 |
| 4 | BLK | 2.67632418 |
| 5 | ERN1 | 2.62318829 |
| 6 | GRK6 | 2.59774848 |
| 7 | MAP3K14 | 2.39357380 |
| 8 | TYK2 | 2.30705408 |
| 9 | CSF1R | 2.28915323 |
| 10 | IRAK4 | 2.27677030 |
| 11 | MAP3K10 | 2.27638215 |
| 12 | STK10 | 2.23268638 |
| 13 | BTK | 2.22019548 |
| 14 | MAP3K13 | 2.20098446 |
| 15 | SYK | 2.18739970 |
| 16 | EEF2K | 2.02546549 |
| 17 | KIT | 1.99210554 |
| 18 | JAK1 | 1.98041619 |
| 19 | IRAK3 | 1.96518040 |
| 20 | LRRK2 | 1.92914584 |
| 21 | PKN2 | 1.87595060 |
| 22 | FES | 1.81526429 |
| 23 | TRIB3 | 1.77853320 |
| 24 | CDK12 | 1.76217956 |
| 25 | TBK1 | 1.74847329 |
| 26 | JAK3 | 1.65694876 |
| 27 | HCK | 1.57204928 |
| 28 | CSK | 1.54592990 |
| 29 | ZAP70 | 1.37417138 |
| 30 | ALK | 1.29865064 |
| 31 | LYN | 1.27500538 |
| 32 | EPHB1 | 1.26264698 |
| 33 | IKBKE | 1.25906151 |
| 34 | NEK2 | 1.25732777 |
| 35 | IKBKB | 1.24927583 |
| 36 | LCK | 1.22301402 |
| 37 | ITK | 1.20341929 |
| 38 | MARK3 | 1.20301249 |
| 39 | TAOK3 | 1.12061455 |
| 40 | CLK1 | 1.02530863 |
| 41 | PIM1 | 1.01359284 |
| 42 | CAMK1G | 0.96950642 |
| 43 | FGR | 0.95605945 |
| 44 | PRKCH | 0.95605066 |
| 45 | PTK6 | 0.88934035 |
| 46 | BRD4 | 0.88268466 |
| 47 | TEC | 0.84934824 |
| 48 | TTN | 0.84523616 |
| 49 | CAMK1D | 0.82052566 |
| 50 | FGFR3 | 0.80910758 |
| 51 | CHUK | 0.79902422 |
| 52 | PRKCQ | 0.77700510 |
| 53 | MAP2K3 | 0.76938853 |
| 54 | MAP3K9 | 0.76529739 |
| 55 | TNK2 | 0.76066350 |
| 56 | TESK2 | 0.66212717 |
| 57 | ABL1 | 0.65746377 |
| 58 | JAK2 | 0.64893332 |
| 59 | CDK4 | 0.63239564 |
| 60 | FGFR4 | 0.63059215 |
| 61 | SIK3 | 0.62757103 |
| 62 | PDK1 | 0.62093327 |
| 63 | STK4 | 0.59902501 |
| 64 | MATK | 0.58112197 |
| 65 | GRK1 | 0.54905523 |
| 66 | EGFR | 0.54643352 |
| 67 | RPS6KA4 | 0.53630013 |
| 68 | TXK | 0.53497652 |
| 69 | MAP3K8 | 0.52694149 |
| 70 | TAOK1 | 0.50733751 |
| 71 | MAPK4 | 0.50150379 |
| 72 | CDK6 | 0.49146661 |
| 73 | MST4 | 0.48700332 |
| 74 | TGFBR2 | 0.47216742 |
| 75 | HIPK2 | 0.46434633 |
| 76 | DYRK1B | 0.45022213 |
| 77 | BMX | 0.44432101 |
| 78 | FYN | 0.44304475 |
| 79 | CDC42BPA | 0.39612685 |
| 80 | SIK1 | 0.39108861 |
| 81 | SCYL2 | 0.37272099 |
| 82 | CDC7 | 0.35405919 |
| 83 | ATR | 0.30935785 |
| 84 | MAP3K7 | 0.30612523 |
| 85 | RPS6KB2 | 0.29046573 |
| 86 | MAPKAPK2 | 0.28589172 |
| 87 | PAK4 | 0.27756552 |
| 88 | INSR | 0.27440960 |
| 89 | PRKCD | 0.27329215 |
| 90 | MAP3K11 | 0.26658875 |
| 91 | PDPK1 | 0.25166300 |
| 92 | MTOR | 0.25116711 |
| 93 | PDGFRB | 0.24938450 |
| 94 | RPS6KA6 | 0.24683617 |
| 95 | CHEK1 | 0.23364543 |
| 96 | MAPK12 | 0.22986198 |
| 97 | RPS6KC1 | 0.22340237 |
| 98 | RPS6KL1 | 0.22340237 |
| 99 | SRC | 0.19289925 |
| 100 | PRKD2 | 0.17141173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.47797313 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.90155046 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63601077 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.52059877 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.47505912 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.47362065 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.42337860 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.01815564 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.01024968 |
| 10 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.96613749 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79404440 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.78479932 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.75407065 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.72045888 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.67681955 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66102387 |
| 17 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.56090422 |
| 18 | Apoptosis_Homo sapiens_hsa04210 | 1.45439487 |
| 19 | Shigellosis_Homo sapiens_hsa05131 | 1.44299833 |
| 20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.44071963 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41835834 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40738554 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.34076283 |
| 24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34071075 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31735058 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.31642865 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30767235 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.27955552 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.23994728 |
| 30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.23692215 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.22114183 |
| 32 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.19022431 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16914324 |
| 34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.16475118 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.16055096 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14435805 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.14333006 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11054137 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 1.10331223 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.06299578 |
| 41 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.05333342 |
| 42 | Asthma_Homo sapiens_hsa05310 | 1.04211608 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03567872 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02570688 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.00210356 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 0.99710265 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.99075083 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93577207 |
| 49 | Base excision repair_Homo sapiens_hsa03410 | 0.91757332 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 0.90948612 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.89746726 |
| 52 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89368910 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88694684 |
| 54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87962184 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87748707 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.87298843 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.87157110 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85651317 |
| 59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84239626 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83854951 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79668724 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79361862 |
| 63 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77821115 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.75214974 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71476555 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.69075731 |
| 67 | DNA replication_Homo sapiens_hsa03030 | 0.68872581 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68618000 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67397606 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66114331 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66048768 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65417733 |
| 73 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64358589 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64157052 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64117404 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62165304 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61909113 |
| 78 | Mismatch repair_Homo sapiens_hsa03430 | 0.61818065 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.60765540 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.59990704 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59481537 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.59218196 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.59189830 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58260054 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53756817 |
| 86 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52846952 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50806637 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48762962 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47632708 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43268089 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43072413 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.40109462 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40016958 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37931818 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37883145 |
| 96 | Spliceosome_Homo sapiens_hsa03040 | 0.37741954 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37712194 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36010284 |
| 99 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.35762096 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35453268 |

